Archives
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as well as data that NSAIDs may not be good […]
Read More
The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates. Discussed in the video are Beers Criteria updates […]
Read More
Benzodiazepines are on the Beers criteria. They can have significant adverse effects like sedation, confusion, the risk for dependence, and increased fall risk. We like to avoid benzodiazepines if we can, but what if we do feel that it is necessary (i.e. hospice or other situation)? I have been asked this question before and will […]
Read More
Parkinson’s is one of the most complex disease states you will encounter. Whenever you talk about a disease of the brain and nervous system, you know that we likely don’t have a 100% clear understanding of how it works and why it happens. However, we definitely know that dopamine plays a critical role in these […]
Read MoreOrthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased risk of adverse effects as well. Here’s the case of assessing orthostasis risk […]
Read More